28 results
S-8
TSBX
Turnstone Biologics Corp
13 May 24
Registration of securities for employees
5:15pm
Law; (iii) the Registrant is required, upon satisfaction of certain conditions, to advance all expenses incurred by its directors in connection
DEF 14A
TSBX
Turnstone Biologics Corp
22 Apr 24
Definitive proxy
4:28pm
on the satisfaction of individual and corporate performance objectives established by our board of directors. Each named executive officer has a target annual
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
an additional 366,884 shares of our common stock in the aggregate upon the satisfaction of certain clinical and regulatory milestones with respect to TIL Products … of our clinical trials;
we may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities that our product
10-K
EX-4.3
xv5ae1wriusxcc
21 Mar 24
Annual report
8:51pm
10-Q
3m24uy szxju
1 Sep 23
Quarterly report
4:39pm
S-8
ka9glmazlk8k6o9q0v72
25 Jul 23
Registration of securities for employees
4:54pm
424B4
tnq13oer0a8
21 Jul 23
Prospectus supplement with pricing info
7:14pm
S-1/A
jmcbvsyay14155c5xh
23 Jun 23
IPO registration (amended)
9:49pm
CORRESP
dpnsif0l
21 Jun 23
Correspondence with SEC
12:00am
S-1
EX-10.8
gyj 050m0uyd
12 Jun 23
IPO registration
4:28pm
S-1
EX-2.1
jpcmp gv5a9d
12 Jun 23
IPO registration
4:28pm
S-1
EX-3.1
c4fvo0
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.9
d1jwd3
12 Jun 23
IPO registration
4:28pm
S-1
t8vy2owi907r1
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.2
ucj yw013afr
12 Jun 23
IPO registration
4:28pm